http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2944149-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R31-316 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R31-3185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R31-316 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R31-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R31-26 |
| filingDate | 1979-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1985-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1985-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-2944149-C2 |
| titleOfInvention | Integrated circuit arrangement in MOS technology |
| abstract | The invention relates to a medicament with an effect on the central nervous system, characterized in that it contains β- [7-hydroxy-naphthyl- (1)] alanine and / or their alkyl esters with 1 to 4 carbon atoms in the alkyl radical as the active substance. |
| priorityDate | 1979-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.